Lung Cancer and Personalized Medicine Current Knowledge and Therapies /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Edición: | 1st ed. 2016. |
| Colección: | Advances in Experimental Medicine and Biology,
893 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-319-24223-1 |
Tabla de Contenidos:
- 1 Lung Cancer Statistics
- 2 Epidemiology of Lung Cancer
- 3 Lung Cancer In Never Smokers
- 4 Immune Therapy
- 5 Anti-angiogenesis in personalized therapy of lung cancer
- 6 Target therapy in Lung Cancer
- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update
- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy
- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer
- 10 Chemotherapy Resistance in Lung Cancer
- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.